Mycophenolate sodium does not reduce the incidence of GI adverse events compared with mycophenolate mofetil

被引：9

作者：

Meier-Kriesche, HU ^{[1
]}

Davies, NM

Grinyó, J

Heading, R

Mamelok, R

Wijngaard, P

Oellerich, M

Maes, B

机构：

[1] Univ Florida, Gainesville, FL USA

[2] Washington State Univ, Pullman, WA 99164 USA

[3] Univ Barcelona, Barcelona, Spain

[4] Royal Infirm, Glasgow G31 2ER, Lanark, Scotland

[5] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[6] Univ Gottingen, Gottingen, Germany

[7] UZ Gasthuisberg, Louvain, Belgium

来源：

AMERICAN JOURNAL OF TRANSPLANTATION | 2005年 / 5卷 / 05期

关键词：

D O I：

10.1111/j.1600-6143.2005.00778.x

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

收藏

页码：1164 / 1164

页数：1

相关论文

共 5 条

[1] Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: Results of a 1-year study
Budde, K
Curtis, J
Knoll, G
Chan, L
Neumayer, HH
Seifu, Y
Hall, M
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) : 237 - 243
[2] Transplant immunosuppressive drug trials on trial
Curtis, JJ
Kaplan, B
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 671 - 672
[3] Reports of large immunosuppression trials in kidney transplantation: Room for improvement
Fritsche, L
Einecke, G
Fleiner, F
Dragun, D
Neumayer, HH
Budde, K
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (05) : 738 - 743
[4] Intravenous mycophenolate mofetil: safety, tolerability, and pharmacokinetics
Pescovitz, MD
Conti, D
Dunn, J
Gonwa, T
Halloran, P
Sollinger, H
Tomlanovich, S
Weinstein, S
Inokuchi, S
Kiberd, B
Kittur, D
Merion, RM
Norman, D
Shoker, A
Wilburn, R
Nicholls, AJ
Arterburn, S
Dumont, E
[J]. CLINICAL TRANSPLANTATION, 2000, 14 (03) : 179 - 188
[5] Enteric-coated mycophenolate sodium is therapeutically equivalent to mycophenolate mofetil in de novo renal transplant patients
Salvadori, M
Holzer, H
de Mattos, A
Sollinger, H
Arns, W
Oppenheimer, F
Maca, J
Hall, M
[J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (02) : 231 - 236